Weston Park Hospital is a health facility specialising in the treatment of cancer in Broomhill, Sheffield, South Yorkshire, England. It is managed by the Sheffield Teaching Hospitals NHS Foundation Trust.

During the past decade, Sheffield Teaching Hospitals NHS Foundation Trust - Weston Park Hospital conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 1 clinical trials were completed, i.e. on average, 14.3% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Sheffield Teaching Hospitals NHS Foundation Trust - Weston Park Hospital" #1 sponsor was "European Organisation for Research and Treatment of Cancer - EORTC" with 6 trials, followed by "Incyte Corporation" with 1 trials sponsored, "Pfizer" with 1 trials sponsored, "Prof Corinne Faivre-Finn" with 1 trials sponsored and "Sheffield Teaching Hospitals NHS Foundation Trust" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sheffield Teaching Hospitals NHS Foundation Trust - Weston Park Hospital" #1 collaborator was "AstraZeneca" with 1 trials as a collaborator, "Belfast Health and Social Care Trust" with 1 trials as a collaborator, "British Lung Foundation" with 1 trials as a collaborator, "Cambridge University Hospitals NHS Foundation Trust" with 1 trials as a collaborator and "Canadian Cancer Trials Group" with 1 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "Sheffield Teaching Hospitals NHS Foundation Trust - Weston Park Hospital" are "Breast Cancer" (1 trials), "Carcinoma, Squamous Cell of Head and Neck" (1 trials), "Central Nervous System Tumors" (1 trials), "Extensive-stage Small-cell Lung Cancer" (1 trials) and "Limited Stage Small Cell Lung Cancer" (1 trials). Many other conditions were trialed in "Sheffield Teaching Hospitals NHS Foundation Trust - Weston Park Hospital" in a lesser frequency.

Most popular intervention types in "Sheffield Teaching Hospitals NHS Foundation Trust - Weston Park Hospital" are "Drug" (8 trials), "Radiation" (3 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Palbociclib" (2 trials), "Placebo" (2 trials), "Temozolomide" (2 trials), "5-FU, Epirubicin, Cyclophosphamide, Docetaxel" (1 trials) and "5-FU, Epirubicin, Cyclophosphamide, Docetaxel, Zoledronic acid" (1 trials). Other intervention names were less common.

The vast majority of trials in "Sheffield Teaching Hospitals NHS Foundation Trust - Weston Park Hospital" are 8 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Sheffield Teaching Hospitals NHS Foundation Trust - Weston Park Hospital". undefined are not yet recruiting, 3 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Sheffield Teaching Hospitals NHS Foundation Trust - Weston Park Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Sheffield Teaching Hospitals NHS Foundation Trust - Weston Park Hospital, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".